RECRUITING

MIND Foods and Aerobic Training in Black Adults With HTN

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized controlled trial is to determine the impact of Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training on cognition in Black adults with high systolic blood pressure. Researchers will compare Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) versus Enhanced Usual Care (EUC) to evaluate the effects on cognition. Participants will complete cognitive and cardiovascular assessments, 24-hr blood pressure monitoring, standard blood pressure measurements, weight, fingerstick for HbA1c point-of-care testing, and questionnaires. Participants may also choose to participate in an optional blood draw for DNA Repair Capacity testing as a modifiable risk factor for aging-associated diseases.

Official Title

MIND Foods and Aerobic Training in Black Adults With HTN: An ADRD Prevention Pilot RCT

Quick Facts

Study Start:2023-11-28
Study Completion:2027-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06152614

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:35 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Fluent in English
  2. 2. Marion County resident
  3. 3. 35-75 years
  4. 4. Self-identified non-Hispanic and Black/African-American/biracial including African-American
  5. 5. Systolic BP of ≥140 in prior 12 months from a primary care visit
  6. 6. Ability to see and read street signs (self report)
  7. 7. Stable housing with independent access to kitchen, including functional stove or hotplate, oven, refrigerator, and freezer (self report)
  8. 8. Activity independence per functional activities questionnaire (FAQ; \<3 responses of "Require Assistance" and 0 responses of "Dependent")
  9. 9. Normal cognition per six-item screener (SIS; score of ≥ 5)
  10. 10. Less than 20min on usual day of moderate or vigorous physical activity
  11. 11. Able to exercise safely per abbreviated Exercise Assessment for You (EASY) or primary care provider clearance
  12. 12. At Eligibility Visit: Mean systolic BP of ≥130 from 24-hour ABPM (from a minimum of 6 daytime readings and 2 nighttime readings)
  1. 1. lives in nursing home
  2. 2. diagnosis of dementia or Alzheimer disease or mild cognitive impairment; Parkinson disease; brain tumor/infection/surgery (within the last 10 years with residual symptoms and/or functional loss/deficit, such as impaired learning, memory, or communication); cancer with short life expectancy, or current chemotherapy or radiation therapy; psychosis, schizophrenia, or bipolar disorder
  3. 3. ICD 10 code I11/hypertensive heart disease, ICD 10 code I12/hypertensive CKD, ICD 10 code I13/hypertensive heart disease and CKD, ICD 10 code I15, or ICD 10 code I16
  4. 4. current or past prescription of donepezil, memantine, rivastigmine, or galantamine
  5. 5. alcohol consumption ≥ 8 drinks per week for women, or ≥15 drinks per week for men
  6. 6. drug use/abuse (excluding marijuana) per EMR
  7. 7. moving out of area during study timeline
  8. 8. scheduling conflicts with intervention schedule
  9. 9. unwilling to use a touchscreen
  10. 10. unwilling to be on video conferencing
  11. 11. low communicative ability, functional status, or other disorders (examiner rated) that would interfere with interventions and assessments
  12. 12. unable to provide informed consent
  13. 13. participation in any lifestyle modification/weight loss program (e.g., Weight Watchers, etc.)

Contacts and Locations

Study Contact

Daniel O Clark, PhD
CONTACT
317-274-9292
daniclar@iu.edu
Lyndsi R Moser, BA, CCRP
CONTACT
317-963-7301
lrhabegg@iupui.edu

Principal Investigator

Daniel O Clark, PhD
PRINCIPAL_INVESTIGATOR
Indiana University

Study Locations (Sites)

Eskenazi Health
Indianapolis, Indiana, 46202
United States

Collaborators and Investigators

Sponsor: Indiana University

  • Daniel O Clark, PhD, PRINCIPAL_INVESTIGATOR, Indiana University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-28
Study Completion Date2027-05-31

Study Record Updates

Study Start Date2023-11-28
Study Completion Date2027-05-31

Terms related to this study

Keywords Provided by Researchers

  • nutrition
  • cooking
  • exercise
  • hypertension

Additional Relevant MeSH Terms

  • Cognitive Decline
  • Hypertension
  • Diet
  • Aerobic Exercise